All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition
On Friday, June 18, 2021, at the 16th International Conference on Malignant Lymphoma (16-ICML), the Lymphoma Hub hosted a virtual satellite symposium on the sequencing of therapies in high-risk relapsed/refractory lymphoma and chronic lymphocytic leukemia (CLL).
The symposium brought together a panel of international experts, who gave their opinion on four distinct cases of patients with primary refractory diffuse large B-cell lymphoma, early relapsing follicular lymphoma, TP53-mutated mantle cell lymphoma, and ibrutinib-resistant CLL. Click to see the presentations by Andrew Davies, Loretta J. Nastoupil, Steven Le Gouill, and Francesc Bosch.
Below you can find the articles published by the Lymphoma Hub in the lead-up to the symposium:
The symposium concluded with an exciting roundtable discussion mediated by Lymphoma Hub Chair Gilles Salles. You can watch the discussion below, where the panelists answered questions submitted by the audience.
Satellite Symposium | Roundtable discussion, summary, and conclusions
In the lead-up to the virtual symposium, the Lymphoma Hub conducted a series of Twitter polls to gain insight into the audience’s understanding of, and interests within, the field of relapsed/refractory lymphoma (Figure 1).
Figure 1. Results of the Lymphoma Hub Satellite Symposium Twitter polls
BTKi, Bruton’s tyrosine kinase inhibitor; CAR-T, chimeric antigen receptor T-cell therapy; CLL, chronic lymphocytic leukemia; DLBCL, diffuse large B-cell lymphoma; FL, follicular lymphoma; MCL, mantle cell lymphoma; PI3Ki, phosphoinositide 3-kinase inhibitor; R/R, relapsed/refractory.
The Lymphoma Hub would like to thank the symposium speakers and attendees for an engaging event!
ASH 2018 | Practice changing abstracts in non-Hodgkin lymphoma and chronic lymphocytic leukemia
Did you miss ASH 2018? The Lymphoma Hub has developed a downloadable resource, which provides information on the practice changing abstracts across...
Prof. Gilles Salles | ASH 2017 | Welcome to Lymphoma Hub
59th ASH Annual Meeting and Exposition, 9 - 12 Dec 2017, Atlanta, GA Professor Gilles Salles South Lyon University Hospital Complex, Lyon, FR Welcome to Lymphoma Hub
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox